Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-09-021520
Filing Date
2009-04-14
Accepted
2009-04-14 16:38:46
Documents
2
Period of Report
2009-04-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4684
2 POA DOCUMENT poa.txt EX-24.4_283117 3923
  Complete submission text file 0001209191-09-021520.txt   10548
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Issuer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O REGENERX BIOPHARMACEUTICALS, INC. 3 BETHESDA METRO CENTER ? SUITE 630 BETHESDA MD 20814
Business Address
Bowles L Thompson (Reporting) CIK: 0001355785 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15070 | Film No.: 09749056